Cell cycle length governs heterochromatin reprogramming during early development in non-mammalian vertebrates
Fukushima, Hiroto S, Ikeda, Takafumi, Ikeda, Shinra, Takeda, Hiroyuki
Published in EMBO reports (09.08.2024)
Published in EMBO reports (09.08.2024)
Get full text
Journal Article
Unlinking the methylome pattern from nucleotide sequence, revealed by large-scale in vivo genome engineering and methylome editing in medaka fish
Cheung, Napo K M, Nakamura, Ryohei, Uno, Ayako, Kumagai, Masahiko, Fukushima, Hiroto S, Morishita, Shinichi, Takeda, Hiroyuki
Published in PLoS genetics (21.12.2017)
Published in PLoS genetics (21.12.2017)
Get full text
Journal Article
TAS-119, a novel selective Aurora A and TRK inhibitor, exhibits antitumor efficacy in preclinical models with deregulated activation of the Myc, β-Catenin, and TRK pathways
Miura, Akihiro, Sootome, Hiroshi, Fujita, Naoya, Suzuki, Takamasa, Fukushima, Hiroto, Mizuarai, Shinji, Masuko, Norio, Ito, Kimihiro, Hashimoto, Akihiro, Uto, Yoshihiro, Sugimoto, Tetsuya, Takahashi, Hidekazu, Mitsuya, Morihiro, Hirai, Hiroshi
Published in Investigational new drugs (01.06.2021)
Published in Investigational new drugs (01.06.2021)
Get full text
Journal Article
Malic enzyme 1 is a potential marker of combined hepatocellular cholangiocarcinoma, subtype with stem‐cell features, intermediate‐cell type
Mihara, Yutaro, Akiba, Jun, Ogasawara, Sachiko, Kondo, Reiichiro, Fukushima, Hiroto, Itadani, Hiraku, Obara, Hitoshi, Kakuma, Tatsuyuki, Kusano, Hironori, Naito, Yoshiki, Okuda, Koji, Nakashima, Osamu, Yano, Hirohisa
Published in Hepatology research (01.09.2019)
Published in Hepatology research (01.09.2019)
Get full text
Journal Article
Targeted in vivo epigenome editing of H3K27me3
Fukushima, Hiroto S, Takeda, Hiroyuki, Nakamura, Ryohei
Published in Epigenetics & chromatin (13.03.2019)
Published in Epigenetics & chromatin (13.03.2019)
Get full text
Journal Article
In Vivo Effects of Cyclosporin A and Ketoconazole on the Pharmacokinetics of Representative Substrates for P-Glycoprotein and Cytochrome P450 (CYP) 3A in Rats
Kageyama, Michiharu, Namiki, Hitomi, Fukushima, Hiroto, Ito, Yukako, Shibata, Nobuhito, Takada, Kanji
Published in Biological & Pharmaceutical Bulletin (01.02.2005)
Published in Biological & Pharmaceutical Bulletin (01.02.2005)
Get full text
Journal Article
Effect of Chronic Administration of Ritonavir on Function of Cytochrome P450 3A and P-Glycoprotein in Rats
Kageyama, Michiharu, Namiki, Hitomi, Fukushima, Hiroto, Terasaka, Shuichi, Togawa, Tatsuya, Tanaka, Akina, Ito, Yukako, Shibata, Nobuhito, Takada, Kanji
Published in Biological & Pharmaceutical Bulletin (2005)
Published in Biological & Pharmaceutical Bulletin (2005)
Get full text
Journal Article
Alteration of dihydropyrimidine dehydrogenase expression by IFN-α affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells
Oie, Shinji, Ono, Mayumi, Fukushima, Hiroto, Hosoi, Fumihito, Yano, Hirohisa, Maruyama, Yuichiro, Kojiro, Masamichi, Terada, Tadafumi, Hirano, Kazuyuki, Kuwano, Michihiko, Yamada, Yuji
Published in Molecular cancer therapeutics (01.08.2007)
Published in Molecular cancer therapeutics (01.08.2007)
Get full text
Journal Article
Abstract P020: Schlafen 11 (SLFN11) as a predictive biomarker of the response to TAS1553, a novel small molecule ribonucleotide reductase subunit interaction inhibitor
Fukushima, Hiroto, Ueno, Hiroyuki, Hoshino, Takuya, Yano, Wakako, Itadani, Hiraku, Terasaka, Miki, Tsukioka, Sayaka, Suzuki, Takamasa, Hara, Shoki, Ogino, Yoshio, Chong, Khoon Tee, Suzuki, Tatsuya, Otsu, Yoshihiro, Ito, Satoshi, Tanaka, Nozomu, Miyahara, Seiji
Published in Molecular cancer therapeutics (01.12.2021)
Published in Molecular cancer therapeutics (01.12.2021)
Get full text
Journal Article